01.11.2005 | Original Research Paper
Rosiglitazone, an agonist of peroxisome proliferator-activated receptor γ, reduces pulmonary inflammatory response in a rat model of endotoxemia
Erschienen in: Inflammation Research | Ausgabe 11/2005
Einloggen, um Zugang zu erhalten